ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2026
First-Trimester Maternal CALLY Index Is Associated With Fetal Growth Restriction.
Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFetal growth restriction (FGR) is a major cause of perinatal morbidity and is frequently associated with placental malperfusion related to inflammatory and immune dysregulation. This study evaluated whether the first-trimester maternal C-reactive protein-albumin-lymphocyte (CALLY) index, a composite marker reflecting systemic inflammation, nutritional status, and immune competence, is associated with subsequent FGR.
methodsThis retrospective case-control study included 105 singleton pregnancies (69 FGR cases and 36 controls) at a tertiary center. FGR was diagnosed according to Delphi consensus criteria. The first-trimester CALLY index was calculated as (albumin × lymphocyte count) / CRP. Placental histopathology was evaluated according to the Amsterdam Placental Workshop Group criteria. Group comparisons were performed using the Mann-Whitney U test and chi-square or Fisher's exact test, and diagnostic performance was assessed using receiver operating characteristic (ROC) analysis.
resultsThe CALLY index was significantly lower in the FGR group compared with controls (0.065 vs 0.170, p < 0.001). FGR cases also had lower birthweight (1910 vs 3120 g, p < 0.001) and placental weight (344.5 vs 585 g, p < 0.001). Maternal vascular malperfusion (MVM) was more frequent in the FGR group (39.1% vs 13.9%, p = 0.015), while fetal vascular malperfusion (FVM) showed borderline significance (63.8% vs 41.7%, p = 0.050). ROC analysis demonstrated modest discriminatory ability for identifying FGR (AUC = 0.739, 95% CI: 0.652-0.826). A CALLY threshold ≤0.1265 yielded 75.4% sensitivity and 66.7% specificity. After adjustment for maternal age, low CALLY remained significantly associated with FGR (adjusted OR: 6.118, 95% CI: 2.529-14.799, p < 0.001). Early-onset FGR cases (≤34 weeks) showed the lowest CALLY values (0.051). Additional ROC analyses for placental malperfusion endpoints showed limited discriminatory ability (AUCs: 0.592-0.636), indicating that CALLY is not a reliable standalone predictor of placental pathology.
conclusionsA low first-trimester maternal CALLY index is associated with subsequent FGR. Its modest discriminatory ability for FGR (AUC = 0.739) suggests it may serve as a complementary tool in multi-parameter risk assessment, particularly when integrated with clinical and sonographic findings. However, the limited performance for placental malperfusion endpoints indicates that CALLY should not be used as a standalone test for predicting placental pathology. Further prospective studies are needed to define its clinical role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.